Marizyme, Inc.
MRZM
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -100.00% | |||
| Cost of Revenue | -- | -100.00% | |||
| Gross Profit | -- | -100.00% | |||
| SG&A Expenses | -21.95% | 20.06% | |||
| Depreciation & Amortization | -10.31% | 11.49% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.75% | 13.13% | |||
| Operating Income | 14.75% | -15.84% | |||
| Income Before Tax | 70.33% | -6.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 70.33% | -6.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 70.33% | -6.10% | |||
| EBIT | 14.75% | -15.84% | |||
| EBITDA | 15.11% | -16.21% | |||
| EPS Basic | 70.26% | -6.14% | |||
| Normalized Basic EPS | -8.33% | 62.76% | |||
| EPS Diluted | 70.26% | -6.14% | |||
| Normalized Diluted EPS | -8.33% | 62.76% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||